Loading…
Octreotide
Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. The content is also available on www.palliativedrugs.com and will feature in future editions of the Hospice and Palliative Care Formulary USA and its British...
Saved in:
| Published in: | Journal of pain and symptom management 2010-07, Vol.40 (1), p.142-148 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c482t-51744a77c63c4320e3a0eb0efe37f52d8dfe1729748dd0af665f8cdaff41af1c3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c482t-51744a77c63c4320e3a0eb0efe37f52d8dfe1729748dd0af665f8cdaff41af1c3 |
| container_end_page | 148 |
| container_issue | 1 |
| container_start_page | 142 |
| container_title | Journal of pain and symptom management |
| container_volume | 40 |
| creator | Murphy, Eva, MRPharm Prommer, Eric E., MD Mihalyo, Mary, BS, PharmD, RPh Wilcock, Andrew, DM, FRCP |
| description | Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. The content is also available on www.palliativedrugs.com and will feature in future editions of the Hospice and Palliative Care Formulary USA and its British and Canadian counterparts. The series editors welcome feedback on the articles ( hq@palliativedrugs.com ). |
| doi_str_mv | 10.1016/j.jpainsymman.2010.05.002 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_870293519</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0885392410003994</els_id><sourcerecordid>870293519</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-51744a77c63c4320e3a0eb0efe37f52d8dfe1729748dd0af665f8cdaff41af1c3</originalsourceid><addsrcrecordid>eNqNkUlLA0EQhRtRTIz-BcGTpxmrt1kuggQ3COSgnptOdzX0OEvsnhHy750hUcSTp4LiVT3e9wi5opBSoNlNlVZb7du4axrdpgzGPcgUgB2ROS1ynmSS8mMyh6KQCS-ZmJGzGCsAkDzjp2TGaMYFiGxOztamD9j13uI5OXG6jnhxmAvy9nD_unxKVuvH5-XdKjGiYH0iaS6EznOTcSM4A-QacAPokOdOMltYhzRnZS4Ka0G7LJOuMFY7J6h21PAFud7_3YbuY8DYq8ZHg3WtW-yGqIocWMklLUdluVea0MUY0Klt8I0OO0VBTSRUpX6RUBMJBVKNJMbby4PLsGnQ_lx-Rx8Fy70Ax6yfHoOKxmNr0PqAple28_-yuf3zxdS-9UbX77jDWHVDaEeYiqrIFKiXqZKpETqWwctS8C8m04iw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>870293519</pqid></control><display><type>article</type><title>Octreotide</title><source>Elsevier</source><creator>Murphy, Eva, MRPharm ; Prommer, Eric E., MD ; Mihalyo, Mary, BS, PharmD, RPh ; Wilcock, Andrew, DM, FRCP</creator><creatorcontrib>Murphy, Eva, MRPharm ; Prommer, Eric E., MD ; Mihalyo, Mary, BS, PharmD, RPh ; Wilcock, Andrew, DM, FRCP</creatorcontrib><description>Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. The content is also available on www.palliativedrugs.com and will feature in future editions of the Hospice and Palliative Care Formulary USA and its British and Canadian counterparts. The series editors welcome feedback on the articles ( hq@palliativedrugs.com ).</description><identifier>ISSN: 0885-3924</identifier><identifier>EISSN: 1873-6513</identifier><identifier>DOI: 10.1016/j.jpainsymman.2010.05.002</identifier><identifier>PMID: 21634046</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anesthesia & Perioperative Care ; Ascites - drug therapy ; Gastrointestinal Agents - adverse effects ; Gastrointestinal Agents - pharmacology ; Gastrointestinal Agents - therapeutic use ; Humans ; Intestinal Obstruction - drug therapy ; Octreotide - adverse effects ; Octreotide - pharmacology ; Octreotide - therapeutic use ; Pain - drug therapy ; Pain Medicine</subject><ispartof>Journal of pain and symptom management, 2010-07, Vol.40 (1), p.142-148</ispartof><rights>U.S. Cancer Pain Relief Committee</rights><rights>2010 U.S. Cancer Pain Relief Committee</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-51744a77c63c4320e3a0eb0efe37f52d8dfe1729748dd0af665f8cdaff41af1c3</citedby><cites>FETCH-LOGICAL-c482t-51744a77c63c4320e3a0eb0efe37f52d8dfe1729748dd0af665f8cdaff41af1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21634046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murphy, Eva, MRPharm</creatorcontrib><creatorcontrib>Prommer, Eric E., MD</creatorcontrib><creatorcontrib>Mihalyo, Mary, BS, PharmD, RPh</creatorcontrib><creatorcontrib>Wilcock, Andrew, DM, FRCP</creatorcontrib><title>Octreotide</title><title>Journal of pain and symptom management</title><addtitle>J Pain Symptom Manage</addtitle><description>Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. The content is also available on www.palliativedrugs.com and will feature in future editions of the Hospice and Palliative Care Formulary USA and its British and Canadian counterparts. The series editors welcome feedback on the articles ( hq@palliativedrugs.com ).</description><subject>Anesthesia & Perioperative Care</subject><subject>Ascites - drug therapy</subject><subject>Gastrointestinal Agents - adverse effects</subject><subject>Gastrointestinal Agents - pharmacology</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Humans</subject><subject>Intestinal Obstruction - drug therapy</subject><subject>Octreotide - adverse effects</subject><subject>Octreotide - pharmacology</subject><subject>Octreotide - therapeutic use</subject><subject>Pain - drug therapy</subject><subject>Pain Medicine</subject><issn>0885-3924</issn><issn>1873-6513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkUlLA0EQhRtRTIz-BcGTpxmrt1kuggQ3COSgnptOdzX0OEvsnhHy750hUcSTp4LiVT3e9wi5opBSoNlNlVZb7du4axrdpgzGPcgUgB2ROS1ynmSS8mMyh6KQCS-ZmJGzGCsAkDzjp2TGaMYFiGxOztamD9j13uI5OXG6jnhxmAvy9nD_unxKVuvH5-XdKjGiYH0iaS6EznOTcSM4A-QacAPokOdOMltYhzRnZS4Ka0G7LJOuMFY7J6h21PAFud7_3YbuY8DYq8ZHg3WtW-yGqIocWMklLUdluVea0MUY0Klt8I0OO0VBTSRUpX6RUBMJBVKNJMbby4PLsGnQ_lx-Rx8Fy70Ax6yfHoOKxmNr0PqAple28_-yuf3zxdS-9UbX77jDWHVDaEeYiqrIFKiXqZKpETqWwctS8C8m04iw</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Murphy, Eva, MRPharm</creator><creator>Prommer, Eric E., MD</creator><creator>Mihalyo, Mary, BS, PharmD, RPh</creator><creator>Wilcock, Andrew, DM, FRCP</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100701</creationdate><title>Octreotide</title><author>Murphy, Eva, MRPharm ; Prommer, Eric E., MD ; Mihalyo, Mary, BS, PharmD, RPh ; Wilcock, Andrew, DM, FRCP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-51744a77c63c4320e3a0eb0efe37f52d8dfe1729748dd0af665f8cdaff41af1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anesthesia & Perioperative Care</topic><topic>Ascites - drug therapy</topic><topic>Gastrointestinal Agents - adverse effects</topic><topic>Gastrointestinal Agents - pharmacology</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Humans</topic><topic>Intestinal Obstruction - drug therapy</topic><topic>Octreotide - adverse effects</topic><topic>Octreotide - pharmacology</topic><topic>Octreotide - therapeutic use</topic><topic>Pain - drug therapy</topic><topic>Pain Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murphy, Eva, MRPharm</creatorcontrib><creatorcontrib>Prommer, Eric E., MD</creatorcontrib><creatorcontrib>Mihalyo, Mary, BS, PharmD, RPh</creatorcontrib><creatorcontrib>Wilcock, Andrew, DM, FRCP</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pain and symptom management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murphy, Eva, MRPharm</au><au>Prommer, Eric E., MD</au><au>Mihalyo, Mary, BS, PharmD, RPh</au><au>Wilcock, Andrew, DM, FRCP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Octreotide</atitle><jtitle>Journal of pain and symptom management</jtitle><addtitle>J Pain Symptom Manage</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>40</volume><issue>1</issue><spage>142</spage><epage>148</epage><pages>142-148</pages><issn>0885-3924</issn><eissn>1873-6513</eissn><abstract>Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. The content is also available on www.palliativedrugs.com and will feature in future editions of the Hospice and Palliative Care Formulary USA and its British and Canadian counterparts. The series editors welcome feedback on the articles ( hq@palliativedrugs.com ).</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21634046</pmid><doi>10.1016/j.jpainsymman.2010.05.002</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-3924 |
| ispartof | Journal of pain and symptom management, 2010-07, Vol.40 (1), p.142-148 |
| issn | 0885-3924 1873-6513 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_870293519 |
| source | Elsevier |
| subjects | Anesthesia & Perioperative Care Ascites - drug therapy Gastrointestinal Agents - adverse effects Gastrointestinal Agents - pharmacology Gastrointestinal Agents - therapeutic use Humans Intestinal Obstruction - drug therapy Octreotide - adverse effects Octreotide - pharmacology Octreotide - therapeutic use Pain - drug therapy Pain Medicine |
| title | Octreotide |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A11%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Octreotide&rft.jtitle=Journal%20of%20pain%20and%20symptom%20management&rft.au=Murphy,%20Eva,%20MRPharm&rft.date=2010-07-01&rft.volume=40&rft.issue=1&rft.spage=142&rft.epage=148&rft.pages=142-148&rft.issn=0885-3924&rft.eissn=1873-6513&rft_id=info:doi/10.1016/j.jpainsymman.2010.05.002&rft_dat=%3Cproquest_cross%3E870293519%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-51744a77c63c4320e3a0eb0efe37f52d8dfe1729748dd0af665f8cdaff41af1c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=870293519&rft_id=info:pmid/21634046&rfr_iscdi=true |